Pfizer (PFE) Sells Capsugel Unit for $2.375B; Trims Revenue Guidance
Tweet Send to a Friend
Pfizer Inc. (NYSE: PFE) announced Monday that it has agreed to sell its Capsugel unit to an affiliate of KKR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


